Corey Alexander Yermus

Corey's experience involves a wide variety of transactional work including mergers and acquisitions (both in the Canadian and cross-border context), debt and equity financings (both domestic and international), public and private securities offerings, take-over bids, initial public offerings and other business combinations. As well, Corey advises clients on a diverse range of unique corporate governance, securities and compliance matters.

With transactional experience in industries including agribusiness and life sciences, technology, regulated industries like consumer products, media & telecom and financial services, Corey assists clients in achieving their goals while safeguarding their interests in the complex transactional landscape. A select scope of his clients include public and private issuers (large, mid-cap as well as emerging), and foreign acquirers of Canadian public entities.

Medicus Pharma Ltd ., in its acquisition of Antev Limited, a clinical stage biotech company, developing Teverelix, a next generation GnRH antagonist, as first in market product for cardiovascular high-risk prostate cancer patients and patients with first acute urinary retention episodes due to enlarged prostate, for consideration of up to approximately US$75 million.

Stay informed with the latest in business and legal commentary, industry updates, webinars and events from the multidisciplinary team at Bennett Jones.